Literature DB >> 31112355

Probiotics for oral and vulvovaginal candidiasis: A review.

Adele Shenoy1, Alice Gottlieb2.   

Abstract

Dermatologists commonly prescribe medications such as antibiotics and corticosteroids that can increase the risk for candidiasis. Though conventional antifungals are often effective against candidiasis, they are not without side effects and species of Candida are gaining resistance. Probiotics help treat conditions such as post-antibiotic diarrhea and infectious diarrhea, and thus have the potential to help with Candida infections, as well. For this reason, we provide an overview of therapies prescribed in dermatology that may increase the risk for candidiasis, and we review the literature on whether probiotics are useful in the treatment and prevention of oral and vulvovaginal candidiasis to help dermatologists treating the condition be better informed about their supplemental use with conventional antifungals.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  candidiasis; lactobacilli; probiotic

Mesh:

Substances:

Year:  2019        PMID: 31112355     DOI: 10.1111/dth.12970

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  9 in total

1.  In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota.

Authors:  Md Abdur Rahim; Hoonhee Seo; Sukyung Kim; Hanieh Tajdozian; Indrajeet Barman; Youngkyoung Lee; Saebim Lee; Ho-Yeon Song
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

2.  Oral Administration of Lactobacillus helveticus LA401 and Lactobacillus gasseri LA806 Combination Attenuates Oesophageal and Gastrointestinal Candidiasis and Consequent Gut Inflammation in Mice.

Authors:  Hélène Authier; Marie Salon; Mouna Rahabi; Bénédicte Bertrand; Claude Blondeau; Sarah Kuylle; Sophie Holowacz; Agnès Coste
Journal:  J Fungi (Basel)       Date:  2021-01-15

Review 3.  COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies.

Authors:  Nafisa Ahmed; Maiesha Samiha Mahmood; Md Asad Ullah; Yusha Araf; Tanjim Ishraq Rahaman; Abu Tayab Moin; Mohammad Jakir Hosen
Journal:  Curr Microbiol       Date:  2022-03-14       Impact factor: 2.343

Review 4.  Probiotics: Potential Novel Therapeutics Against Fungal Infections.

Authors:  Yunjian Wu; Shan Hu; Changyu Wu; Feng Gu; Ying Yang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-21       Impact factor: 5.293

Review 5.  Probiotics for Oral Candidiasis: Critical Appraisal of the Evidence and a Path Forward.

Authors:  Linda S Archambault; Anna Dongari-Bagtzoglou
Journal:  Front Oral Health       Date:  2022-04-14

Review 6.  Probiotics for the Prevention of Antibiotic-Associated Diarrhea.

Authors:  Kira Kopacz; Sangita Phadtare
Journal:  Healthcare (Basel)       Date:  2022-08-02

Review 7.  Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion.

Authors:  Gilbert Donders; István Oszkár Sziller; Jorma Paavonen; Phillip Hay; Francesco de Seta; Jean Marc Bohbot; Jan Kotarski; Jordi Antoni Vives; Bela Szabo; Ramona Cepuliené; Werner Mendling
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073

8.  Development of a Mucoadhesive in Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity.

Authors:  Barbara Vigani; Angela Faccendini; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Pietro Grisoli; Franca Ferrari
Journal:  Pharmaceutics       Date:  2019-10-03       Impact factor: 6.321

9.  In Vitro Exploration of Probiotic Bacteria Interactions with Candida Using Culture Techniques to Model Dysbiotic Conditions in Colonized Tissues.

Authors:  Emma Wittman; Neela Yar; Francesco De Seta; Bryan Larsen
Journal:  Pathogens       Date:  2021-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.